Strong fundamental in place for Sun Pharma: Nimish Mehta, Delta Advisors
  • WebDesk BTVI
  • Jul 16 2019

Nimish Mehta from Delta Advisors is bullish on Sun Pharma from a long-term perspective. He says strong fundamental is in place for Sun Pharma which is leading to its ramp up. He, however, adds that FY20 will not be so significant for the company given its guidance and expects the company’s margin to be beyond 24% in two years.